Literature DB >> 7531216

Human immunodeficiency virus type 2 (HIV-2) env gene analysis: prediction of glycoprotein epitopes important for heterotypic neutralization and evidence for three genotype clusters within the HIV-2a subtype.

J Breuer1, N W Douglas, N Goldman, R S Daniels.   

Abstract

The env gene sequences of ten tissue-culture-adapted human immunodeficiency virus type 2 (HIV-2) isolates from West African patients were determined. Alignment and comparison of the gene sequences and putative translation products with database sequences revealed 11-29% diversity at the nucleotide level and 15-31% variation at the protein level. From analysis of glycoproteins of HIV-2 strains sensitive and resistant to neutralization by HIV-1 antisera, five regions were identified as putative targets for cross-neutralizing antibody. The HIV-2 equivalent of the HIV-1 V3 loop was not included in this number. However, three of the HIV-2 peptides aligned with regions identified as targets for broad neutralization of HIV-1 strains. These were the V2 and CD4-binding domains of gp120 and the Kennedy domain in gp41. Phylogenetic analysis of the env gene sequences, together with HIV-2 env gene sequences published in the Los Alamos database, support the identification of two distinct HIV-2 subtypes, HIV-2a and HIV-2b. The new sequences are located within the HIV-2a subtype and allow prediction of at least three genotypes, designated I-III. Some correlation of genotype with geographical origin of isolates was noted. Genotype I viruses originate from Guinea Bissau and group II viruses mainly originate from The Gambia. One isolate from Guinea Bissau, HIV-2CAM4, appears phylogenetically older than other viruses in the HIV-2a subtype. The possible implications of this in the light of epidemiological findings in Guinea Bissau are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7531216     DOI: 10.1099/0022-1317-76-2-333

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  5 in total

1.  Molecular investigation of human immunodeficiency virus type 2 subtype a cases in South Korea.

Authors:  Jeong-Gu Nam; Gab Jung Kim; Jin Young Baek; Soon Duck Suh; Mee Kyung Kee; Joo-Shil Lee; Sung Soon Kim
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

2.  A neutralizing monoclonal antibody previously mapped exclusively on human immunodeficiency virus type 1 gp41 recognizes an epitope in p17 sharing the core sequence IEEE.

Authors:  E Buratti; S G Tisminetzky; P D'Agaro; F E Baralle
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

3.  Location, exposure, and conservation of neutralizing and nonneutralizing epitopes on human immunodeficiency virus type 2 SU glycoprotein.

Authors:  A McKnight; C Shotton; J Cordell; I Jones; G Simmons; P R Clapham
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

4.  Localized sequence heterogeneity in the long terminal repeats of in vivo isolates of equine infectious anemia virus.

Authors:  W Maury; S Perryman; J L Oaks; B K Seid; T Crawford; T McGuire; S Carpenter
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  A genotypic method for determining HIV-2 coreceptor usage enables epidemiological studies and clinical decision support.

Authors:  Matthias Döring; Pedro Borrego; Joachim Büch; Andreia Martins; Georg Friedrich; Ricardo Jorge Camacho; Josef Eberle; Rolf Kaiser; Thomas Lengauer; Nuno Taveira; Nico Pfeifer
Journal:  Retrovirology       Date:  2016-12-20       Impact factor: 4.602

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.